These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Polymorphisms in the dopamine, serotonin, and norepinephrine transporter genes and their relationships to monoamine metabolite concentrations in CSF of healthy volunteers. Jönsson EG, Nöthen MM, Gustavsson JP, Neidt H, Bunzel R, Propping P, Sedvall GC. Psychiatry Res; 1998 Jun 02; 79(1):1-9. PubMed ID: 9676821 [Abstract] [Full Text] [Related]
5. Monoamine metabolites in ventricular CSF of children with posterior fossa tumors: correlation with tumor histology and cognitive functioning. Varela M, Alexiou GA, Liakopoulou M, Papakonstantinou E, Pitsouni D, Alevizopoulos GA. J Neurosurg Pediatr; 2014 Apr 02; 13(4):375-9. PubMed ID: 24559277 [Abstract] [Full Text] [Related]
6. Dystrobrevin-binding protein 1 gene (DTNBP1) variants associated with cerebrospinal fluid homovanillic acid and 5-hydroxyindoleacetic acid concentrations in healthy volunteers. Andreou D, Saetre P, Kähler AK, Werge T, Andreassen OA, Agartz I, Sedvall GC, Hall H, Terenius L, Jönsson EG. Eur Neuropsychopharmacol; 2011 Sep 02; 21(9):700-4. PubMed ID: 21295953 [Abstract] [Full Text] [Related]
7. HTR2C Cys23Ser polymorphism in relation to CSF monoamine metabolite concentrations and DSM-III-R psychiatric diagnoses. Lappalainen J, Long JC, Virkkunen M, Ozaki N, Goldman D, Linnoila M. Biol Psychiatry; 1999 Sep 15; 46(6):821-6. PubMed ID: 10494451 [Abstract] [Full Text] [Related]
8. [Concentrations of monoamines and monoamine metabolites in cerebrospinal fluid determined by high-performance liquid chromatography with electrochemical detection]. Yoshino K. No To Shinkei; 1982 Nov 15; 34(11):1099-106. PubMed ID: 6186264 [Abstract] [Full Text] [Related]
9. Cerebrospinal fluid levels of monoamine metabolites. A preliminary study of their relation to menstrual cycle phase, sex steroids, and pituitary hormones in healthy women and in women with premenstrual syndrome. Eriksson E, Alling C, Andersch B, Andersson K, Berggren U. Neuropsychopharmacology; 1994 Nov 15; 11(3):201-13. PubMed ID: 7532413 [Abstract] [Full Text] [Related]
10. Cerebrospinal fluid monoamine metabolite concentrations in depressive disorder: A meta-analysis of historic evidence. Ogawa S, Tsuchimine S, Kunugi H. J Psychiatr Res; 2018 Oct 15; 105():137-146. PubMed ID: 30219563 [Abstract] [Full Text] [Related]
11. Dopamine-related genes and their relationships to monoamine metabolites in CSF. Jönsson E, Sedvall G, Brené S, Gustavsson JP, Geijer T, Terenius L, Crocq MA, Lannfelt L, Tylec A, Sokoloff P, Schwartz JC, Wiesel FA. Biol Psychiatry; 1996 Nov 15; 40(10):1032-43. PubMed ID: 8915563 [Abstract] [Full Text] [Related]
12. Cerebroventricular size and cerebrospinal fluid monoamine metabolites in schizophrenic patients and healthy volunteers. Nybäck H, Berggren BM, Hindmarsh T, Sedvall G, Wiesel FA. Psychiatry Res; 1983 Aug 15; 9(4):301-8. PubMed ID: 6196802 [Abstract] [Full Text] [Related]
13. Genetics of monoamine metabolites in baboons: overlapping sets of genes influence levels of 5-hydroxyindolacetic acid, 3-hydroxy-4-methoxyphenylglycol, and homovanillic acid. Rogers J, Martin LJ, Comuzzie AG, Mann JJ, Manuck SB, Leland M, Kaplan JR. Biol Psychiatry; 2004 Apr 01; 55(7):739-44. PubMed ID: 15039003 [Abstract] [Full Text] [Related]
14. Effect of vagus nerve stimulation on cerebrospinal fluid monoamine metabolites, norepinephrine, and gamma-aminobutyric acid concentrations in depressed patients. Carpenter LL, Moreno FA, Kling MA, Anderson GM, Regenold WT, Labiner DM, Price LH. Biol Psychiatry; 2004 Sep 15; 56(6):418-26. PubMed ID: 15364040 [Abstract] [Full Text] [Related]
15. Sampling issues of cerebrospinal fluid and plasma monoamines: Investigation of the circadian rhythm and rostrocaudal concentration gradient. Janssens J, Atmosoerodjo SD, Vermeiren Y, Absalom AR, den Daas I, De Deyn PP. Neurochem Int; 2019 Sep 15; 128():154-162. PubMed ID: 31034914 [Abstract] [Full Text] [Related]
16. Cerebrospinal fluid monoamine metabolites in fluoxetine-treated patients with major depression and in healthy volunteers. De Bellis MD, Geracioti TD, Altemus M, Kling MA. Biol Psychiatry; 2019 Sep 15; 33(8-9):636-41. PubMed ID: 7687151 [Abstract] [Full Text] [Related]
18. Monoamine metabolites in cerebrospinal fluid during acute cerebral ischemia. Tang HZ, Lu XF, Wang KJ, Ou YS, Huang YQ. Chin Med J (Engl); 1989 Jan 15; 102(1):18-23. PubMed ID: 2475306 [Abstract] [Full Text] [Related]
19. Associations between a locus downstream DRD1 gene and cerebrospinal fluid dopamine metabolite concentrations in psychosis. Andreou D, Söderman E, Axelsson T, Sedvall GC, Terenius L, Agartz I, Jönsson EG. Neurosci Lett; 2016 Apr 21; 619():126-30. PubMed ID: 26957229 [Abstract] [Full Text] [Related]
20. Reduced cerebrospinal HVA concentrations and HVA/5-HIAA ratios in suicide attempters. Monoamine metabolites in 120 suicide attempters and 47 controls. Engström G, Alling C, Blennow K, Regnéll G, Träskman-Bendz L. Eur Neuropsychopharmacol; 1999 Sep 21; 9(5):399-405. PubMed ID: 10523046 [Abstract] [Full Text] [Related] Page: [Next] [New Search]